Cargando…
Conformational Studies of Glucose Transporter 1 (GLUT1) as an Anticancer Drug Target
Glucose transporter 1 (GLUT1) is a facilitative glucose transporter overexpressed in various types of tumors; thus, it has been considered as an important target for cancer therapy. GLUT1 works through conformational switching from an outward-open (OOP) to an inward-open (IOP) conformation passing t...
Autores principales: | Almahmoud, Suliman, Wang, Xiaofang, Vennerstrom, Jonathan L., Zhong, Haizhen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600248/ https://www.ncbi.nlm.nih.gov/pubmed/31181707 http://dx.doi.org/10.3390/molecules24112159 |
Ejemplares similares
-
Molecular Modeling Studies on the Binding Mode of the PD-1/PD-L1 Complex Inhibitors
por: Almahmoud, Suliman, et al.
Publicado: (2019) -
Expression of the glucose transporters GLUT1, GLUT3, GLUT4 and GLUT12 in human cancer cells
por: Barron, Carly, et al.
Publicado: (2012) -
Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers
por: Krzeslak, Anna, et al.
Publicado: (2012) -
Functional Expression of the Human Glucose Transporters GLUT2 and GLUT3 in Yeast Offers Novel Screening Systems for GLUT-Targeting Drugs
por: Schmidl, Sina, et al.
Publicado: (2021) -
Glucose transporters GLUT1, GLUT3, and GLUT4 have different effects on osteoblast proliferation and metabolism
por: Arponen, Milja, et al.
Publicado: (2022)